State of New Jersey Common Pension Fund D’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.53M Sell
47,460
-1,935
-4% -$136K 0.01% 736
2026
Q1
$3.67M Sell
49,395
-2,501
-5% -$181K 0.01% 686
2025
Q4
$3.97M Buy
51,896
+246
+0.5% +$16.1K 0.01% 659
2025
Q3
$2.68M Sell
51,650
-5,476
-10% -$267K 0.01% 833
2025
Q2
$2.47M Buy
57,126
+3,760
+7% +$137K 0.01% 825
2025
Q1
$1.84M Sell
53,366
-39,765
-43% -$1.34M 0.01% 1145
2024
Q4
$2.56M Buy
93,131
+16,545
+22% +$428K 0.01% 850
2024
Q3
$1.95M Buy
76,586
+9,225
+14% +$242K 0.01% 1337
2024
Q2
$1.71M Sell
67,361
-12,596
-16% -$344K 0.01% 1423
2024
Q1
$2.47M Sell
79,957
-6,815
-8% -$232K 0.01% 1477
2023
Q4
$3.5M Buy
86,772
+4,588
+6% +$138K 0.01% 835
2023
Q3
$2.17M Buy
+82,184
New +$2.33M 0.01% 1468
2022
Q1
Sell
-65,853
Closed -$1.1M 1708
2021
Q4
$1.1M Buy
65,853
+9,930
+18% +$420K ﹤0.01% 1705
2021
Q3
$2.62M Buy
55,923
+11,309
+25% +$606K 0.01% 1405
2021
Q2
$2.72M Buy
44,614
+9,720
+28% +$555K 0.01% 1201
2021
Q1
$2.15M Buy
+34,894
New +$2.28M 0.01% 1520

Other funds holding BBIO

State of New Jersey Common Pension Fund D's BBIO Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its BridgeBio Pharma (BBIO) stake by 3.9% in Q2 2026, selling an estimated $136K and leaving 47,460 shares worth $3.53M. The position accounts for 0.01% of the portfolio, ranked #736.

State of New Jersey Common Pension Fund D first reported a position in BBIO in Q1 2021 and has held it in 16 quarters since. The position peaked at $3.97M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 47,460 shares of BridgeBio Pharma worth $3.53M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 1,935 BridgeBio Pharma shares in Q2 2026, an estimated $136K.
  • BridgeBio Pharma made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #736 holding.
  • State of New Jersey Common Pension Fund D first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 16 quarters since.
  • State of New Jersey Common Pension Fund D's BridgeBio Pharma position peaked at $3.97M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.